Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103193607B reveals green ionic liquid catalysis for chalcone. Reduces waste and improves supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN109535079B reveals a solvent-free organic acid catalyzed route for 2,4,5-trisubstituted imidazoles, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN104876877A reveals high-purity synthesis for Candesartan intermediates. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN114574454B details enzymatic synthesis for Tenofovir intermediates. Discover cost-effective, scalable biocatalytic solutions for pharmaceutical manufacturing.
Patent CN104152505A details enzymatic production of 4-HIL. Offers high yield and scalable supply chain solutions for diabetes treatment intermediates.
Patent CN102060710A details a selective synthesis route for O-nitrobenzaldehyde. This method offers significant supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Novel ionic liquid synthesis for carbazoles via patent CN118255708A. Metal-free catalysis ensures cost-effective and reliable supply for pharmaceutical intermediates.
Patent CN107827816B reveals a metal-free graphene oxide catalytic method for high-yield formamide derivative synthesis, offering significant cost reduction and supply chain stability.
Novel synthesis of pentafluorocarbonyl oxo methyl carboxylate via patent CN120736981B. Delivers high yield, environmental safety, and scalable supply chain solutions for global pharmaceutical manufacturing.
Patent CN107382644A reveals a Pd-catalyzed route for high-purity chiral tertiary alcohols. Discover cost reduction in chiral drug manufacturing and supply advantages.
Novel enzymatic route for L-alpha amino acids. High yield, eco-friendly process. Reliable supply chain partner for pharmaceutical intermediates.
Patent CN106365949A reveals a breakthrough in chiral spiroindane synthesis, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Novel patent CN104370769B enables robust production of Saxagliptin intermediates with improved purity and supply chain stability for global pharmaceutical partners.
Patent CN115466756A discloses novel immobilized transaminases for sitagliptin production. Achieve high conversion, stability, and cost reduction in pharmaceutical manufacturing.
Patent CN117467733B reveals immobilized transaminase process for Sitagliptin. Achieve high optical purity and cost reduction in API manufacturing with scalable biocatalysis.
Patent CN117362140A reveals a photoredox synthesis method for cyclohexyl substituted styrenes. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable visible-light catalysis.
Novel method for lapatinib intermediates using recyclable Pd catalyst. Enhances purity and reduces environmental impact for pharma manufacturing.
Patent CN106795542B details (R)-selective cupin enzymes for chiral beta-nitroalcohol synthesis, offering high purity and cost reduction in API manufacturing.
Patent CN104530062B details a green L-proline catalyzed route for high-purity 1,4-naphthoquinone derivatives offering significant supply chain and cost advantages.
Discover the novel Co-catalyzed process for 4-chloro-4'-hydroxybenzophenone. Enhanced purity, reduced waste, and scalable manufacturing for fenofibrate intermediates.